Kong Lingyan, Huang Hui
Objective To investigate the impact of DRGs-based payment implementation on the hospitalization costs for patients undergoing surgery for uterine fibroids, as well as changes in the cost structure, with a view to informing the implementation of DRGs-based payment.This study provides a reference framework for reducing hospital costs and improving hospital management for patients undergoing surgery for uterine fibroids. Method: The selected period for discharge was from January 1 to December 31, 2021.The patients who underwent surgery for uterine fibroids belonged to the DRGs pre-payment group, while those who were discharged between January 1 and December 31, 2023, belonged to the DRGs post-payment group. The analysis employed t-tests and χ2 tests.The data on age, length of hospital stay, and hospital expenses for a total of 2,177 patients undergoing uterine fibroid surgery in two groups were compared and analyzed using structural changes.We analyzed the composition and trends of changes in the costs associated with hospitalization for both groups. Results Show that before and after the implementation of DRGs, the average length of hospital stay, total costs, examination and laboratory fees, treatment expenses, medication costs, and other expenses remained largely unchanged.The differences in material costs were statistically significant (P < 0.05). The total costs, examination and laboratory fees, medication expenses, and material costs all decreased. The total costs had dropped from 18,033.44 before the implementation of the policy.(15,969.10, 20,186.78) yuan decreased to 15,904.71 (14,171.53, 17,966.67) yuan following the implementation of the policy. The most significant decrease was observed in the cost of medications.The proportion of fees and examination/laboratory costs has decreased, with corresponding structural change values of –8.97% and –1.63%, respectively. The proportion of treatment-related costs has increased, with a structural change value of 9.69%. Conclusion The implementation of DRGs has effectively reduced the hospitalization costs for patients undergoing surgery for uterine fibroids. There has been a noticeable improvement in the structure of hospitalization costs, with a positive shift in the proportion of treatment-related costs and reductions in medication and examination expenses.The negative change in the composition of laboratory fee structures has enhanced the value of medical staff’s technical skills. This information can serve as a reference for further optimizing hospital management and improving the control of DRG costs.